Cabozantinib,Nivolumab,Ipilimumab
BMS
['nivo', 'ipilimumab', 'ts,perio,i', 'cabozantinib', 'nivolumab']
#asco23 late-breaker: cabozantinib (c) with nivolumab and ipilimumab superior than c alone for non-translocation #sts. more information at: #meded 
COR2ED bringing you Independent Medical Education developed 
by SARCOMA CONNECT, international experts in sarcoma